Core Viewpoint - The company reported a significant decline in overall revenue and a reduction in losses compared to the previous year, primarily due to changes in China's healthcare policies and intense market competition [1] Financial Performance - The overall revenue for the six months ending December 31, 2025, was RMB 267 million, representing a year-on-year decrease of 39.5% [1] - The loss attributable to shareholders for the period was RMB 6.1 million, an improvement from a loss of RMB 8 million in the same period of 2024 [1] - The loss per share was RMB 0.0621, compared to RMB 0.1000 (restated) for the six months ending December 31, 2024 [1] Market Factors - The decrease in revenue was attributed to adjustments in China's healthcare insurance policies and fierce market competition [1] - A reduction in sales and marketing expenses helped to offset the revenue decline during the period [1]
大健康国际(02211.HK)中期整体收益2.67亿元 同比减少39.5%